Technical Analysis for ORPH - Open Orphan Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
![]() |
5.15 | -10.82% | -0.63 |
ORPH closed down 10.82 percent on Monday, December 9, 2019, on 9.54 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Down |
See historical ORPH trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Expansion Breakdown | Bearish Swing Setup | 0.00% | |
Reversal New Lows Setup | Bearish Swing Setup | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Venn Life Sciences Holdings plc is a clinical research organization (CRO), which is engaged in providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations. The Company has the innovation segment, which is focused on developing and commercializing skin technologies. It provides drug development services through its subsidiary, Kinesis Pharma B.V. The Company's drug development services include clinical development, pharmaceutical development, non-clinical/pre-clinical development, drug candidate selection and drug development project management. The Company offers international clinical research services, including protocol development; feasibility and site selection; investigator and site selection; project management; site management and monitoring; vendor management, and quality assurance. The Company has its presence in the United Kingdom, Ireland, France, Netherlands, Germany and Singapore.
Articles Biotechnology Health Project Management Pharmaceutical Industry Drug Discovery Drug Development Clinical Trial Clinical Research Contract Research Organizations Parexel Clinical Research Services Drug Development Services Pharmaceutical Development Site Management Clinical Trial Services Dokumeds Drug Development Project Management Medical Statistics Skin Technologies Vendor Management
Articles Biotechnology Health Project Management Pharmaceutical Industry Drug Discovery Drug Development Clinical Trial Clinical Research Contract Research Organizations Parexel Clinical Research Services Drug Development Services Pharmaceutical Development Site Management Clinical Trial Services Dokumeds Drug Development Project Management Medical Statistics Skin Technologies Vendor Management
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 8.15 |
52 Week Low | 4.799 |
Average Volume | 586,045 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 6.24 |
20-Day Moving Average | 6.19 |
10-Day Moving Average | 6.01 |
Average True Range | 0.25 |
ADX | 21.96 |
+DI | 10.26 |
-DI | 42.84 |
Chandelier Exit (Long, 3 ATRs ) | 5.83 |
Chandelier Exit (Short, 3 ATRs ) | 5.54 |
Upper Bollinger Band | 6.79 |
Lower Bollinger Band | 5.58 |
Percent B (%b) | -0.35 |
BandWidth | 19.67 |
MACD Line | -0.17 |
MACD Signal Line | -0.07 |
MACD Histogram | -0.0988 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.73 | ||||
Resistance 3 (R3) | 6.78 | 6.32 | 6.46 | ||
Resistance 2 (R2) | 6.32 | 5.92 | 6.29 | 6.38 | |
Resistance 1 (R1) | 5.73 | 5.67 | 5.50 | 5.68 | 6.29 |
Pivot Point | 5.27 | 5.27 | 5.15 | 5.24 | 5.27 |
Support 1 (S1) | 4.68 | 4.86 | 4.45 | 4.62 | 4.01 |
Support 2 (S2) | 4.22 | 4.62 | 4.19 | 3.92 | |
Support 3 (S3) | 3.63 | 4.22 | 3.84 | ||
Support 4 (S4) | 3.57 |